Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6517062 | 0.86 | ALDH1A1 (0.47) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL6514389 | 0.83 | LMNA (0.45) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL6514905 | 0.80 | ALDH1A1 (0.42) | ALDH1A1SLC15A1MAPK1L3MBTL1KMT2A | |
| SCHEMBL1195221 | 0.80 | ALDH1A1 (0.59) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL3959738 | 0.77 | ALDH1A1 (0.54) | ALDH1A1SLC15A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL4900863 | 0.76 | SLC15A1 (0.59) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL4896293 | 0.76 | SLC15A1 (0.59) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL12369646 | 0.76 | SLC15A1 (0.59) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL111390 | 0.76 | ALDH1A1 (0.61) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 | |
| SCHEMBL7406398 | 0.74 | ALDH1A1 (0.59) | ALDH1A1SLC15A1MAPK1L3MBTL1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ALDH1A1 1254/4885SLC15A1 3390/4885MAPK1 1916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.